These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9633523)

  • 1. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
    Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A; Jindal SK; Brown TJ; Letarte M
    Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
    Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
    J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
    Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
    Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
    Bassing CH; Shou W; Muir S; Heitman J; Matzuk MM; Wang XF
    Cell Growth Differ; 1998 Mar; 9(3):223-8. PubMed ID: 9543388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
    Bruckheimer EM; Kyprianou N
    Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T; Moustakas A; Lin HY; Lodish HF
    Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Lang S; Kato M; Oefelein MG; Miyazono K; Nemeth JA; Kozlowski JM; Lee C
    Clin Cancer Res; 1996 Aug; 2(8):1255-61. PubMed ID: 9816295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.